OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2020-12-31-accounts

Somerset Unit for Radiotherapy Equipment.

Charity Registration No. 1102299. surecharity.org.uk 44 Calder Crescent, Taunton, Somerset, TA1 2NH

ANNUAL REPORT & FINANCIAL STATEMENTS

YEAR ENDED 31[ST] DECEMBER 2020

Sections

  1. Charity Information

  2. Report of the Executive Committee

  3. Financial Reserves policy

  4. Report of the Independant Examiner

  5. SURE Vision 2020 and Beyond

SURE Annual Report 2020 1 of 15

4 July 2021

Section 1. S.U.R.E. CHARITY INFORMATION For Year Ending 31st December 2020

TRUSTEES Paul Alway Roy Hole Vanessa Marchmont Barrie Palmer EXECUTIVE COMMITTEE P W Alway (Chairman) B Palmer (Founder) V.H.R.Hole (Vice Chair & Hon.Financial Director) V Marchmont. (Secretary) C Summerfield (Treasurer) S Miller G Wills REGISTERED OFFICE 44 Calder Crescent Taunton, Somerset, TA1 2NH BANKERS CAF Bank Ltd 25 Kings Hill Avenue Kings Hill, West Malling Kent, ME19 4JQ Lloyds/TSB 31 Fore St, Taunton, TA1 1HN Bath Building Society c/o MJC Financial Planning Ltd 22 South Street Wellington TA21 8NS

Scottish Widows 67 Morrison Street Edinburgh, EH3 8YJ

Shawbrook Lutea House The Drive, Great Warley Brentwood, CM13 3BE

Skipton Building Society 1 Cheapside Taunton, TA1 3LG

INDEPENDANT EXAMINER

Tax Assistance Accountants 24 Bridge Street Taunton, TA1 1UB

SURE Annual Report 2020

4 July 2021

2 of 15

Section 2. Report of the Executive Committee

The members of the Executive Committee, including all Trustees, present their Report and the Audited Financial Statement of the Charity for the year ended 31[st] December 2020.

LEGAL STATUS

S.U.R.E. is a fund raising charity and was founded in the year 2000. It became a Registered Charity in 2004 and the registered number is 1102299.

PRINCIPAL ACTIVITY

The principal activity of the charity is to raise funds for radiotherapy equipment used in the treatment of cancer patients at the Beacon Centre, Musgrove Park Hospital, Taunton.

REVIEW OF THE YEAR

The ability of SURE to fund new projects in 2020 has been severely restricted by the impact of the ongoing Covid-19 pandemic on NHS resources and the focus of the Beacon Centre during 2020 was quite rightly to continue patient treatment, at the expense of planning for any new equipment to be provided with SURE funding, whilst completing the replacement of the third radiotherapy treatment machine (Linear Accelerator/Linac).

As a result the SURE Committee and Trustees took the decision not to actively promote fundraising for the charity during 2020 as this would have impacted on wider NHS fundraising to combat Covid-19. This resulted in a drop in donations from fundraisers and supporters, unable to run their usual fundraising events in 2020, of around 50% on the previous year.

Early in 2020 SURE received a significant legacy, left to the charity in a supporters will, as reflected in the Financial report, this has put the charity in an excellent position to be able to fund the Radiotherapy projects currently identified for the next 2 years.

Total donations received in 2020 was £932,206 made up of: Donations £60,012 ; Legacies £868,279; Interest Received £3,915.

Whilst funding of projects in 2020 was limited by the impact of Covid-19, S.U.R.E. has been able to pass to the Beacon Centre and Musgrove Park Hospital the sum of £37,092 to fund the purchase of equipment and services, and in the true tradition of the charity, expenses have been kept to a minimum at £542 for the year. General expenses also included Liability Insurance, postage,licenses, professional fees and bank charges. Total expenditure was £37,634 and the net income £894,572.

The projects funded by SURE are as listed in the following pages of this section titled ‘SURE- Equipment Provided during 2020, which also includes a look at the way ahead in 2021 where SURE expects to fund additional equipment to ensure the Beacon Centre is able to make best use of the advanced treatment capabilities offered by the 3 new Linacs as soon as practically possible to the benefit of patients.

In recent years the SURE AGM / Annual Supporters Meeting has taken place at the Beacon Centre and include a detailed tour of the Radiotherapy Department to show supporters where their donations have been used to the benefit of patients. SURE was unable to hold any meetings at the hospital in 2020, as a result the AGM could not take place. It is hoped that as the country reopens the 2021 meeting will be able to be held at the Beacon Centre later in the year.

This whole report was compiled by Chairman Paul Alway, with a major contribution from Treasurer Carole Summerfield, and help as needed from Roy Hole.

SURE Annual Report 2020

4 July 2021

3 of 15

– SURE Equipment Provided during 2020

During 2020 SURE committed funding of £37,092 to providing items of equipment to the Radiotherapy Department at the Beacon Centre at Musgrove Park Hospital to further improve patient diagnosis, treatment and outcomes. Whilst the Radiotherapy Department continued with the replacement of the third radiotherapy treatment machine (Linac) during the Covid-19 pandemic, the focus of the Beacon Centre during 2020 was quite rightly to continue patient treatment at the expense of planning for any new equipment to be provided with SURE funding.

Projects Funded by SURE in 2020:

  1. SURE allocated funding to the Radiotherapy Department to purchase laptops and software to enable staff to work remotely as and when required during the Covid-19 pandemic, at a final cost to SURE of £19,758.24

  2. SURE funded the DICOM Modality Worklist module for MOSAIQ, to provide imaging devises used in oncology such as CT, MRI and PET, with a direct, electronic transfer of patient information from the MOSAIQ patient record system at a cost to SURE of £5,044.74

  3. SURE approved funding in 2019 for the replacement of the patient information storage system, Network Attached Storage, NAS, at a cost to SURE of £12,288.96, paid in 2020.

  4. SURE also approved funding for a number of small item projects to support the ongoing work of the Radiotherapy team, all expected to be invoiced for payment in 2021:

  5. £1,865.82 approved funding for monitor rails to better hold the monitors in the radiotherapy control room.

  6. £131 approved funding for provision of Spiroball Incentive Spirometers,

  7. £812.25 approved funding the purchase of additional Valley cushions and covers to provide comfort to patients during travel to/from the Beacon Centre.

  8. £335 approved funding of replacement power chargers for the Apple iPads used by the radiotherapy team.

The Way Ahead

SURE is committed to ensuring cancer services at Musgrove Park Hospital, and the Beacon Centre in particular, continues to offer high quality cancer care to internationally recognised standards, as SURE continues to provide equipment and support not otherwise available within the NHS budget that is assessed to be of real benefit to patients.

SURE is committed to supporting the introduction of new and improved cancer diagnosis and treatments, enabling the Beacon Centre and wider Oncology departments at Musgrove Park Hospital to participate in national cancer treatment trials, leading to more patients being able to be treated locally at the Beacon Centre.

As outlined in the annual report for 2019 the committee and trustees worked with the Radiotherapy Department to produce a shared Vision for Radiotherapy to kick-start the provision of funding for new equipment by SURE before the end of 2020, outlining where SURE support and funding might best be used to the benefit of patients. During 2020 meetings with the Radiotherapy team continued utilising Microsoft Teams meetings and email. As a result, in November 2020 the SURE committee and Trustees agreed a new Vision and Roadmap paper for the future development of advanced radiotherapy services with the Radiotherapy team, an extract of which is included under Section 5. The Vision & Roadmap is not set in stone, it is a living document setting out an agreed pathway for key areas of development over the next few years and it is anticipated that it will evolve as projects move forward.

As a result we have an ambitious programme of projects for the coming year, potentially requiring SURE funding of up to £650,000, including funding for :

SURE Annual Report 2020

4 July 2021

4 of 15

Whilst the Covid pandemic continues to impact the NHS it is not known how many of the projects proposed for 2021 will be able to be delivered in 2021, some may well have to move into 2022.

From the Vision Roadmap the following projects received early approval and initial funding before the end of 2020, expected to be invoiced for payment in 2021:

  1. Development of the Beacon Buddy mobile phone App, funding of £30,825 approved.

  2. 1[st] element of the Space Conversion project, funding of £4,137.08 approved.

  3. GafChromic Film for the SABR project, funding of £5,851 approved.

Section 3. Financial Reserves Policy

The S.U.R.E. Financial Reserves Policy is based upon a number of factors:

  1. Forecast and historic annual income levels from fundraising activities, excluding legacy donations.

  2. Historic underlying funding expenditures on equipment and services to maintain the treatment capabilities of the Radiotherapy Department at the Beacon Centre, Musgrove Park Hospital, excluding major funding undertakings such as replacing the S.U.R.E. funded CT Scanner/Simulator.

  3. S.U.R.E. Does not commit to funding equipment unless the funds are readily available in S.U.R.E.'s bank accounts, the exception being for major undertakings such as replacing the S.U.R.E. CT Scanner where given the high cost an individual fundraising campaign is run.

  4. The need to hold reserves against committed expenditure forecasts for future years, such as the ongoing maintenance of equipment funded by S.U.R.E. where a commitment has been made to fund multiple years maintenance costs, such as where S.U.R.E. committed tom pay the first 3 years maintenance costs for the S.U.R.E. CT scanner.

  5. S.U.R.E.'s Reserves Policy is to maintain reserves of a minimum of £100,000 in the charities bank accounts

  6. S.U.R.E. will not commit expenditure of any portion of the £100,000 financial reserve without the unanimous agreement of the Management Committee and the authority of ALL Trustees confirmed in writing to the Secretary.

  7. This will enable S.U.R.E. to fund the provision of equipment urgently required by the

SURE Annual Report 2020

4 July 2021

5 of 15

Radiotherapy Department to ensure patient treatment is maintained at current levels of excellence.

Section 4. Report of the Independant Examiner

S.U.R.E. Somerset Unit for Radiotherapy Equipment 110229

Report and Accounts for the Year ended 31st December 2020

This page left blank

SURE Annual Report 2020 6 of 15

4 July 2021

S.U.ILE. 110229 REPORTOF THE TRUSTEES The th8¥1ty i% a T￿lr¥Or￿ar￿$8tts)n to equiwnentforthe tre1tmentofcar￿r ￿tients and thÈrefore is rash basedwith rK• of rf5¢Y•m. ￿ OKWate5asafoL71 receiv¢rgpointfo¥the tash generated frJThJ rai5ir¥eventsaThl has￿minIscUI￿ aM￿j￿tOf operati expenditure. Itwa5 founded intheyear2Ctharxl became a re￿ter￿dd￿itylTh2l I(￿0Me InEome larKe 6*18 34.739 49.250 64,617 93.768 159.074 153039 165.952 255,044 301,289 174.774 154,930 161.165 117.111 135.035 294.892 297.267 130564 192.623 521201 928,291 6.818 34.843 49.843 66.682 97,456 167.501 169.140 187.207 321.392 307,549 178,1 160,202 164.752 118,935 6,128 296.378 6.818 34.843 49.843 66.555 97,212 167,138 268,Y)5 186,731 306,856 1225,672 B2.875 184,6301 275.(￿3 1125.8811 14A32 185.156 227.771 19.778 1299,416 28X 894.572 6￿18 41,661 91,504 158.059 255.271 422.409 591.314 718,ts15 LW,901 859.229 942.104 857.474 58Z391 456.510 470.942 656.098 883069 903.647 604.231 632.739 1,527,311 2￿1 2￿2 2CrfJ3 104 593 IC65 12441 13631 12351 14761 11971 13141 I2.1￿) 11751 14321 16641 15281 11,077 ii.ux)I ii.wi IL649 (J.370 15421 2(M15 2W6 2C¥J7 2(M)8 8.427 .301 2L255 1143391 522,gJ71 193,0531 1244,6571 439A031 1244.1521 I￿1,168) 110.1451 170,7141 1112.0821 491.1621 14943131 137.0921 6.260 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 5.272 3587 L824 L093 2.278 2.454 3.772 133.018 196.395 524.191 932.2( 3,915 SURE Annual Report 2020 7of15 4 July 2021

S.U.R.L 110229 INCOME & EXPENDITURE ACCOUNT fortheyearended 31st DetemL*r 2020 INCOMIMG RESOUR Donatior LeRaues GiftAEd InteTe5t ReoNed Bank Adjustment 60.0 868,279 124295 394.267 2￿37 3,915 $24J RESOURCE5 EXPENDED Equipment Purthased 37m2 494?13 Fundra￿recosts Tr8¥ PostsRe Stationery Webstte Iwranre 76 137 65 124 324 310 Profes5Ksnal Fees Bankcharges 150 65 37 495W4 NEf INCO Is￿7 SURE Annual Report 2020 8of15 4 July 2021

U.R.E. 110229 BALANCE SHE fortheYe8remded 3tst Def*mbef 2020 CIIRREl￿ASWs Cash at Bankand in Hand 1527311 631739 L527311 611739 8alancebrou8htfoThvawd 631739 6￿231 894572 28.508 634739 and5wed on tts behaifby.. V.H.R. Hole, WKe(hairmHn C Sufflrnerf￿l￿Tre￿ Pa￿AlWaY. Chaim)ars SURE Annual Report 2020 9of15 4 July 2021

S.U.R.E. I￿229 Statement of Cashllows as at 31st t)ecember2020 20 89J.657 25,518 3915 894￿71 BaL•nce fon¥ard 631739 fTh.231 Ba￿￿orried fcn¥ard 1527311 631739 SURE Annual Report 2020 IOof15 4 July 2021

&U.R.E. 110229 NOTE5 TO THE FINANCIAL sfATEMENrs as at 315t December2020 lal Bas￿ of prep•rath)n Recommended Practice: Ac(ountir¥and Rewtin8 byctharibes preparir¥their accounts in accordan￿w1ththÈ FiTrarKial ReytingSlandardappIits￿e UK and Republicof Ireland IFRS 1021 ￿ue{lOO 16Juty2014andthe ￿nar￿laT RewbryStand&rd appliolAe in the United fI￿d0M and RewNic of ITel8nd IFRS 1021 ondthE OkiwitiesAct2011and UK Gene¢a1tyAc￿pted Practi￿ it applie5 frnm lJanuary2015. The trusteescortskler thatthere are rK) rrbateri81 uncertainlies abouttt tharivs ability to contifiue as a goiwcorttrn.Thereare rbp) material uwtaintie5 affe£ifjwthecurrent vearfs Ibl Ful￿ struttsire All fvnd58re unresirt Icl IrKomir re50urths AJI intomiw resourw are reoyi5ed up¢)n recdrL Idl lrtom5wTesourrosfrom iE83aE5 Idl Resour￿ exp￿dedand irreti7verableVAT headings thataggregate am costs re￿ted10 each cegoryof expense inthe Income & Expendr(ureAc¢wnt Irrecoverable vATIsd￿￿alTh*th2cat￿￿ ofresour expended for whith ltwas irKurred. P426 SURE Annual Report 2020 Ilof15 4 July 2021

U.R.E. 110229 INDEPENDENT EXAMINER'S REPORT Tnssfiforthewdrerthd 3tst December 2020 assettyAon pys 1.6. acwrd8n￿￿Ith Ihe reqwrements ofthelJwritie5Pd 2011 lhe4YI. I report in respectof myexamiTr3tioDof theTnJsVs accouTrts rArriEd oul urKIErsEctson 145 ofthe 2011 lt and it) carrwwow myexamiwion, I ha%t fdknwed all thE applKable Directionsgr¥n ￿ theCharityComrniEian undErse£tion 14515llbl rftheAct The thariV$ grossincorne exceeded É250.(m and l arn walrfied to undertake the examination bybeirga qUaIrf￿ memberof The Irtsiituteof Fin8rKs•l Accountsnt& I havetomF4eted myexamination. I confifftthrn material rnalt￿ hwecometo my attention in CL￿r￿0￿ withthe eAaminaDon lotherthan thatdisdtssed bdow'l whith ¥e5 mt£auseto Ww4ethat in, arry rwerial respert: Act.. or • the accounts dld Mtcompwwth The aFfthabJe requ1rernents(￿nteml￿gthefornI and toment of accounts set our ITh￿ th4ritiEs (￿C￿nts3Thd Reports) Regulatiorts2(X)8 other than arby requirementthattheaccouThts ￿n￿andIa1￿￿1￿kth hnot a matter con5iderÈd as partof an it)deperthntexamirthtion. exarnination to W￿Ch attemw)n should bedra￿ in this Yryort in onkrto enat4e a proper 20thAwl 2021 Name= Edw¥d Cot£￿ LTCLAFWMIPA SURE Annual Report 2020 12of15 4 July 2021

Thes¢ Fin2nCAai Statements vtte approveAJ by th¢ Exttutive ComTDittee & TtU5t¢es 2020 on 29° July 2021 atMI on beljalf by: Payl Alway, Chairm•n: Carole SummerfiekL V.H.Roy Vwe Chxirm# t£ft Blank SURE Annual Rwrt 2020 13of15 4 July 2021 SURE Annual Report 2020 13of15 4 July 2021

Section 5. SURE Vision 2020 and beyond.

The Radiotherapy Department of the Beacon Centre in Musgrove Park Hospital is very grateful to the dedicated committee members and volunteers who strive to raise funds to support radiotherapy in Somerset. Without their dedication we would not be able to deliver the vital treatments to the people of Somerset.

The aim of this paper is to highlight the collaborative work that we have achieved in recent years and to describe how we aspire to move forward together.

The roadmap below shows a simplistic strategy for radiotherapy, how SURE have supported us already and how we would like to develop in the next few years.

Projects for the Future

Radiotherapy App - This supports patients through their radiotherapy pathway.

Staff Room - As a very busy cancer centre, the teams at Musgrove care for all the cancer patients who come through our doors. It is important that we, in turn, care for our staff and provide them with facilities to enable them to get the required rest and sustenance. To this end we are working with SURE to replace the tired staff room and refurbish it. Well rested and fed staff provide safer more caring services to patients.

Sterotactic Ablative Body Radiotherapy (SABR) - NHS England has confirmed that we are now rolling out SABR across the country and Somerset FT (SFT) has risen to the challenge. Whilst a few years ago, we were delivering lung SABR, we are now privileged to work this up for lung, lung oligometastases, bone (not spine) oligometastases and lymph and adrenal oligomtastases. This is wonderful for our patients, who previously would have had to travel to Bristol or beyond for this treatment. We have a comprehensive project plan being worked on currently but will need support for equipment to deliver this:

Workspace/Patient Space - In these difficult times of social distancing, we have had to become very creative to ensure that our patients get the care they need whilst providing a safe environment to those

SURE Annual Report 2020

4 July 2021

14 of 15

who must come for treatment. To this end we are looking to create the right “online” clinic spaces to support the privacy and dignity of our patients whilst maintaining excellent care even though they may not be in the department.

We are hoping to create some clinic pods and a review room.

Radium 223 (Ra223) - Radium-223 Dichloride injections are currently recommended by NICE for the treatment of hormone resistant metastatic prostate cancer mostly for disease in their bones, where other treatment options have been exhausted or are contraindicated in the individual. Currently, Somerset patients have to travel to Bristol for this treatment but many are unable to endure the journey so this treatment becomes unavailable to them. We hope to change that for our patients. We also anticipate that this treatment will also become available to metastatic breast patients

We are hoping to build a radium suite and will need support to purchase some of the essential equipment such as a ventilated fume cabinet, a radiation monitoring device and computers and a metal radiation safe for example.

Training Needs - This will support the staff to become the best they can be, researching treatments, changing the way we deliver treatment and delivering the very best, evidence based treatments in our centre. Education is power!

In 2021, our professional bodies advocate academic underpinning in the form of Masters Degrees in radiotherapy topics to ensure that the correct research ideologies and methods are employed in our drive for the best care for patients.

EPROMs - This is a cancer programme which enables us to collate Patient Reported Outcome Measures will help us understand real time patient experience and define the future of services and cancer treatments.

Equipment - We know that radiotherapy equipment is very expensive and we aim to have the best to make sure we serve our patients well.

Alongside the replacement of some existing, quality assurance equipment such as our MAP check and ARC check (to ensure the calibration of our larger equipment for patient safety, we are also aspiring to move forward with the technology with some more innovative technology.

We hope that this will give you a better understanding of the developments, small, medium and large that we are working on currently and how we could benefit from all the work that the SURE team put in to help us achieve our aims. The future of our radiotherapy service is shared.

SURE Annual Report 2020

4 July 2021

15 of 15